Related references
Note: Only part of the references are listed.Effects of prolonged exendin-4 administration on hypothalamic-pituitary-adrenal axis activity and water balance
Manuel Gil-Lozano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors
Alexandra E. Butler et al.
DIABETES (2013)
β-cell adaptation in a mouse model of glucocorticoid-induced metabolic syndrome
Liselotte Fransson et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease
Annika Mehlem et al.
NATURE PROTOCOLS (2013)
Emerging combinatorial hormone therapies for the treatment of obesity and T2DM
Sharon A. Sadry et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes
Carolina E. Hagberg et al.
NATURE (2012)
Early intervention with liraglutide improves glucose tolerance without affecting islet microcirculation in young Goto-Kakizaki rats
Lin Wu et al.
REGULATORY PEPTIDES (2012)
Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells
Margot M. L. Linssen et al.
CELLULAR SIGNALLING (2011)
Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans
Daniel H. van Raalte et al.
DIABETES CARE (2011)
Morphofunctional Alterations in Endocrine Pancreas of Short- and Long-term Dexamethasone-treated Rats
A. Rafacho et al.
HORMONE AND METABOLIC RESEARCH (2011)
LXR beta is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice
Rucha Patel et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential
S. S. Torekov et al.
OBESITY REVIEWS (2011)
Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents
John B. Buse et al.
DIABETES CARE (2010)
Glucocorticoids in Vivo Induce Both Insulin Hypersecretion and Enhanced Glucose Sensitivity of Stimulus-Secretion Coupling in Isolated Rat Islets
Alex Rafacho et al.
ENDOCRINOLOGY (2010)
Chronic Corticosterone Exposure Increases Expression and Decreases Deoxyribonucleic Acid Methylation of Fkbp5 in Mice
Richard S. Lee et al.
ENDOCRINOLOGY (2010)
Endocrine and Physiological Changes in Response to Chronic Corticosterone: A Potential Model of the Metabolic Syndrome in Mouse
Ilia N. Karatsoreos et al.
ENDOCRINOLOGY (2010)
High doses of dexamethasone induce increased β-cell proliferation in pancreatic rat islets
Alex Rafacho et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
Michael Nauck et al.
DIABETES CARE (2009)
Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
Bernard Zinman et al.
DIABETES CARE (2009)
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
M. Marre et al.
DIABETIC MEDICINE (2009)
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
D. Russell-Jones et al.
DIABETOLOGIA (2009)
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
Alan Garber et al.
LANCET (2009)
Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4
F Ranta et al.
DIABETES (2006)
Serum- and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion
S Ullrich et al.
DIABETES (2005)
Changes in insulin secretion and glucose metabolism induced by dexamethasone in lean and obese females
C Besse et al.
OBESITY RESEARCH (2005)
Mechanisms involved in the side effects of glucocorticoids
H Schäcke et al.
PHARMACOLOGY & THERAPEUTICS (2002)
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety - effect of obesity and weight reduction
C Verdich et al.
INTERNATIONAL JOURNAL OF OBESITY (2001)
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
AMJ Shapiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
